Skip to main content
OpenTrials
Completed

NCT Number: NCT02055261

Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease

The appearance of postural instability and gait disorders is a major turning point in the evolution of Parkinson's disease (PD). These axial symptoms are usually unresponsive to L-Dopa and represent a severe impairment for the patients due to frequent falls and reduced outside mobility. There is no effective pharmacological treatment available for these symptoms, and their pathophysiology is not well known : it is currently assumed that non-dopaminergic brainstem lesions participate to axial symptoms in PD. Surgically, these patients cannot benefit from high frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) since this operation tends to even aggravate axial symptoms unresponsive to L-Dopa in some patients. A dysfunction of the pedunculopontine nucleus (PPN) might be at the origin of these axial symptoms, since the PPN participates in the maintenance of posture and motion in primates. In PD patients, recent reports have suggested that low frequency stimulation of the PPN may equally improve gait and posture. However, these results are debatable due to methodological limitations, insufficient clinical evaluation and uncertain anatomical targeting. Thus, our aim is to propose a low frequency PPN stimulation to six advanced PD patients according to the usual criteria for STN DBS who are, however, unsuitable for this operation due to gait and posture disorders. We will perform a randomized, double-blind and cross over design (two months periods with and without DBS randomly assigned to each patient). The targeting will be allowed by a a three-dimensional and deformable atlas of the basal ganglia fusioned with the stereotaxic magnetic resonance imaging (MRI) of each patient. Evaluations will comprise 1 month before surgery and in "Off" and "On" stimulation condition:

* clinical motor assessment in both "Off" and "On" drug state, including cardinal parkinsonian signs, gait and balance * gait initiation physiological evaluation * cognitive and behavioral testing If our hypothesis is confirmed, low frequency PPN stimulation may well represent a substantial improvement of our therapeutic options for advanced PD patients suffering from debilitating gait and posture disorders unresponsive to L-Dopa.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Hôpital de la Pitié-Salpétrière

Paris, 75013, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Parkinson's disease
  • Age < 70 and > = 18 years
  • Improvement > or = 50 % during acute levodopa test
  • Score > or = 2 on item 29 of UPDRS part 3 score obtained in "off" drug state
  • No previous DBS
  • No evidence of atypical parkinsonism
  • No dementia (MATTIS > 129)
  • No psychiatric disease
  • Contraception if woman
  • Informed consent

Exclusion criteria

  • Contra indication to surgery
  • Contra indication to MRI
  • Severe life threatening comorbidity

Treatment and study plan

Low frequency DBS of the pedunculopontine nucleus

Device

Primary outcomes

  1. Change of Rating scale for gait evaluation between 'Off stim off drug" and "On stim off drug" conditions

    Time frame: 4 months and 6 months after surgery

    The primary outcome criteria will be the comparison between RSGE total score in obtained 'Off' and 'On' stimulation conditions either at 4 or 6 months after surgery according to the randomized order of the cross-over

Secondary outcomes

  1. Adverse events records

    Time frame: 1 month before surgery, 1-2-3-4-5-6 months after surgery

  2. Change of UPDRS part 3 score between "Off Stim Off drug" and "ON stim Off drug" conditions

    Time frame: 4 and 6 months after surgery

  3. Change of Rating scale for gait evaluation between 'Off stim on drug" and "On stim on drug" conditions

    Time frame: 4 and 6 months after surgery

  4. Change of UPDRS part 3 score between "Off Stim On drug" and "ON stim On drug" conditions

    Time frame: 4 and 6 months after surgery

  5. Change of UPDRS part 3 score between "Off Stim Off drug" and "No stim Off drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  6. Change of UPDRS part 3 score between "Off Stim On drug" and "No stim On drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  7. Change of Rating scale for gait evaluation between 'Off stim Off drug" and "No stim off drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  8. Change of Rating scale for gait evaluation between 'Off stim On drug" and "No stim on drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  9. Change of Rating scale for gait evaluation between 'On stim Off drug" and "No stim off drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  10. Change of Rating scale for gait evaluation between 'On stim On drug" and "No stim On drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  11. Change of gait physiological parameters between "Off Stim Off drug" and "ON stim Off drug" conditions

    Time frame: 4 and 6 months after surgery

  12. Change of gait physiological parameters between "Off Stim On drug" and "ON stim On drug" conditions

    Time frame: 4 and 6 months after surgery

  13. Change of gait physiological parameters between "No Stim On drug" and "Off stim On drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  14. Change of gait physiological parameters between "No Stim Off drug" and "On stim off drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  15. Change of gait physiological parameters between "No Stim Off drug" and "Off stim off drug" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

Other outcomes

  1. Changes in sleep architecture between "off stim" and "on stim" conditions

    Time frame: 4 and 6 months after surgery

  2. changes in cognitive evaluation between "Off stim" and 'On stim" conditions

    Time frame: 4 and 6 months after surgery

  3. changes in cognitive evaluation between "No stim" and 'Off stim" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

  4. changes in cognitive evaluation between "No stim" and 'On stim" conditions

    Time frame: 1 month before surgery and 4 or 6 months after surgery

Sponsors and collaborators

Lead sponsor

Pitié-Salpêtrière Hospital

Other

Registry information

Official study title

Effects of Low Frequency Deep Brain Stimulation of the Pedunculopontine Nucleus on Gait and Balance Disorders of Parkinson's Disease

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Feb 5, 2014
Registry last updated
Feb 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.